Kernicterus and Neonatal Jaundice Malpractice Claims in NY

The Bilirubin Pathway: Why Jaundice Becomes Dangerous

Bilirubin is a yellow compound produced when red blood cells break down. In newborns, red blood cells are broken down at a higher rate than in adults because fetal hemoglobin is replaced with adult hemoglobin. The baby's liver, which is still maturing, may not be able to process bilirubin fast enough, causing it to accumulate in the blood — this is neonatal jaundice.

In most cases, the bilirubin level stays within a safe range, and jaundice resolves within 1-2 weeks. But in some babies — particularly those with risk factors like prematurity, blood type incompatibility, or infections — bilirubin levels can rise rapidly to dangerous levels.

When bilirubin in the blood reaches very high concentrations, it can cross the blood-brain barrier — the protective filtering mechanism that normally prevents toxins from entering the brain. Once in the brain, bilirubin is toxic to neurons, particularly in the basal ganglia (which controls movement) and the brainstem nuclei (which controls hearing, eye movement, and other critical functions).

The specific level at which bilirubin becomes dangerous depends on the baby's gestational age, the presence of risk factors, and the rate of rise. The American Academy of Pediatrics (AAP) has published detailed bilirubin nomograms that guide clinicians on when to intervene.

How Kernicterus Happens: The Standard of Care

The medical standard of care for preventing kernicterus is well-established and straightforward. The tragedy of kernicterus is that it should never happen when the standard of care is followed:

1. Universal bilirubin screening: The AAP recommends that all newborns have a total serum bilirubin (TSB) or transcutaneous bilirubin (TcB) measurement before discharge from the hospital, typically at 24-48 hours of life.

2. Risk factor assessment: Every newborn should be assessed for risk factors that increase the danger of hyperbilirubinemia, including prematurity, exclusive breastfeeding with inadequate intake, blood type incompatibility (ABO or Rh), G6PD deficiency, cephalohematoma or bruising, and a sibling with prior severe jaundice.

3. Plotting on the bilirubin nomogram: The bilirubin level must be plotted on an hour-specific nomogram to determine the percentile and risk zone. A level that is acceptable at 24 hours may be dangerous at 72 hours.

4. Phototherapy: When bilirubin reaches the threshold for phototherapy (based on the nomogram and risk factors), the baby should be placed under phototherapy lights, which convert bilirubin to a form that can be excreted in urine and stool.

5. Exchange transfusion: If bilirubin reaches very high levels despite phototherapy, or if the rate of rise suggests imminent danger, an exchange transfusion must be performed — replacing the baby's blood with donor blood to rapidly reduce bilirubin levels.

6. Follow-up: Babies discharged before 48 hours of age must have a follow-up bilirubin check within 1-2 days, as bilirubin typically peaks at 3-5 days of life.

Signs and Symptoms of Acute Bilirubin Encephalopathy

When bilirubin reaches neurotoxic levels, the baby develops acute bilirubin encephalopathy (ABE) — the acute phase of brain injury that progresses to chronic kernicterus if untreated. The signs progress through three phases:

Phase 1 (Early): - Lethargy and sleepiness - Poor feeding or suckling - Hypotonia (floppiness) - Slight high-pitched cry

Phase 2 (Intermediate): - Hypertonia (spasticity), particularly of the extensor muscles - Arching of the back (retrocollis/opisthotonos) - Irritability and shrill, high-pitched cry - Fever

Phase 3 (Advanced): - Pronounced retrocollis-opisthotonos (severe backward arching) - Apnea and respiratory distress - Seizures - Coma and death

Any baby showing signs of Phase 2 or Phase 3 ABE requires immediate exchange transfusion. A delay of even hours can mean the difference between a full recovery and permanent brain damage.

Long-Term Consequences of Kernicterus

Once kernicterus develops, the brain damage is permanent and irreversible. The long-term consequences include:

• Athetoid cerebral palsy: Involuntary, slow, writhing movements of the face, trunk, and limbs that worsen with stress and effort. This is the most prominent feature of kernicterus.
• Sensorineural hearing loss: Damage to the auditory nerve and brainstem auditory nuclei. Many children require hearing aids or cochlear implants.
• Gaze palsies: Difficulty with upward gaze (Parinaud syndrome), and sometimes horizontal gaze palsy.
• Intellectual disability: While intelligence may be relatively preserved in some children, many have cognitive impairments that affect learning and independence.
• Speech and language delays: Due to hearing loss, motor impairment affecting speech production, and cognitive issues.
• Seizure disorders: Some children develop epilepsy.
• Dental enamel hypoplasia: Abnormal tooth development leading to dental problems.

When Jaundice Becomes Medical Malpractice

Kernicterus is almost always preventable. When it occurs, it typically means that one or more of the following breaches occurred:

• Failure to screen bilirubin: The hospital did not perform a bilirubin test before discharge, or the test was performed but the results were not reviewed before the baby went home.
• Failure to plot on the nomogram: The bilirubin level was measured but not interpreted in the context of the baby's age in hours and risk factors.
• Failure to recognize risk factors: Prematurity, blood type incompatibility, or other risk factors were present but not factored into the treatment decision.
• Failure to initiate phototherapy: The bilirubin level met the threshold for phototherapy, but treatment was delayed or not initiated.
• Failure to escalate to exchange transfusion: The bilirubin level continued to rise despite phototherapy, but exchange transfusion was not performed in time.
• Failure to provide follow-up: The baby was discharged early without a scheduled follow-up bilirubin check, and the level rose to dangerous levels at home.
• Failure to recognize acute bilirubin encephalopathy: The baby showed signs of lethargy, poor feeding, or abnormal muscle tone, but these were dismissed rather than recognized as signs of brain injury.

Risk Factors for Severe Hyperbilirubinemia

The standard of care requires clinicians to assess every newborn for risk factors that increase the danger of severe hyperbilirubinemia:

• Prematurity: Babies born before 38 weeks have immature livers that process bilirubin more slowly. The earlier the gestational age, the higher the risk.
• Blood type incompatibility (ABO or Rh): When the mother and baby have different blood types, maternal antibodies can attack the baby's red blood cells, increasing bilirubin production.
• G6PD deficiency: An enzyme deficiency (more common in males of African, Mediterranean, or Asian descent) that causes red blood cells to break down more rapidly.
• Exclusive breastfeeding with inadequate intake: 'Breastfeeding jaundice' occurs when the baby is not getting enough milk, leading to dehydration and higher bilirubin levels.
• Cephalohematoma or significant bruising: Blood pooling under the scalp or in tissues breaks down into bilirubin, increasing the load.
• East Asian ethnicity: Higher baseline bilirubin levels and higher rates of severe hyperbilirubinemia.
• Sibling history: A previous sibling with severe jaundice increases the risk.
• Infection: Sepsis or other infections can impair bilirubin processing.

Diagnosis and Treatment: What Should Have Happened

In a properly managed case, the following should have occurred:

1. Prenatal blood typing: The mother's blood type and Rh factor should have been determined during pregnancy, with antibody screening.

2. Cord blood testing: If the mother is Rh-negative or has a blood type that creates incompatibility risk, cord blood should be tested for bilirubin and blood type.

3. Universal bilirubin screening at 24-48 hours: Every newborn should have a bilirubin level measured before discharge.

4. Nomogram plotting: The result should be plotted on an hour-specific bilirubin nomogram to determine the risk zone.

5. Risk factor assessment: The medical team should document the presence or absence of all risk factors.

6. Phototherapy when indicated: If the level meets the threshold, phototherapy should be initiated promptly — not delayed.

7. Follow-up appointment: If the baby is discharged before 48 hours of life, a follow-up bilirubin check should be scheduled within 1-2 days.

8. Exchange transfusion when necessary: If bilirubin rises to dangerous levels despite phototherapy, exchange transfusion must be performed without delay.

When kernicterus occurs, we typically find that one or more of these steps was skipped, delayed, or performed incorrectly.

Building a Kernicterus Malpractice Case

At MDLaw Firm, we build kernicterus cases through a meticulous, evidence-based approach:

1. Medical record review: We obtain all prenatal, delivery, nursery, and pediatric records, including laboratory results for bilirubin levels.

2. Expert consultation: We engage board-certified pediatricians and neonatologists to evaluate whether the standard of care for jaundice management was followed.

3. Causation analysis: We work with pediatric neurologists to confirm that the child's brain injury is consistent with kernicterus (rather than HIE or another cause).

4. Damases calculation: We work with lifecare planners to project the lifelong cost of care — which, for a child with athetoid cerebral palsy and hearing loss, can be $5-10 million or more.

5. Litigation: We file the case, conduct discovery, and prepare for trial while remaining open to fair settlement.

We handle kernicterus cases on a contingency fee basis — you pay nothing unless we secure compensation for your family.

New York Statute of Limitations

Under New York's CPLR § 214-a, the general statute of limitations for medical malpractice is 2.5 years. Under the infant tolling rule (CPLR § 208), the statute is tolled for minors until age 18, meaning the injured child has until approximately age 20 to file a claim on their own behalf.

A parent's derivative claim for medical expenses is subject to the standard 2.5-year deadline and is not tolled. New York does not cap non-economic damages in medical malpractice cases, and a certificate of merit (CPLR § 3012-a) is required.

Frequently Asked Questions

The value of a medical malpractice case in New York depends on several factors, including the severity of the injury, the strength of liability evidence, and the economic and non-economic damages involved. New York is one of the few states with no caps on medical malpractice damages, meaning there is no artificial limit on what you can recover. Below are typical settlement ranges based on injury severity.